Invention Grant
- Patent Title: Triazolopyridine compounds
- Patent Title (中): 三唑并吡啶化合物
-
Application No.: US13308588Application Date: 2011-12-01
-
Publication No.: US08349824B2Publication Date: 2013-01-08
- Inventor: Alexander Flohr , Luca Gobbi , Katrin Groebke Zbinden , Matthias Koerner , Jens-Uwe Peters
- Applicant: Alexander Flohr , Luca Gobbi , Katrin Groebke Zbinden , Matthias Koerner , Jens-Uwe Peters
- Applicant Address: US NJ Nutley
- Assignee: Hoffmann-La Roche Inc.
- Current Assignee: Hoffmann-La Roche Inc.
- Current Assignee Address: US NJ Nutley
- Agent George W. Johnston; Patricia S. Rocha-Tramaloni; Kimberly J. Prior
- Priority: EP10194014 20101207
- Main IPC: A61K31/397
- IPC: A61K31/397 ; A61K31/55 ; A61K31/541 ; A61K31/5355 ; A61K31/437 ; C07D243/00 ; C07D279/10 ; C07D413/14 ; C07D471/04
Abstract:
The invention is concerned with triazolopyridine compounds of formula (I) wherein R1, R2, R3 and R4 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit PDE10A and can be used as pharmaceuticals.
Public/Granted literature
- US20120142665A1 TRIAZOLOPYRIDINE COMPOUNDS Public/Granted day:2012-06-07
Information query
